Abstract
Recently, genome-wide association studies of breast cancer revealed single nucleotide polymorphisms (SNPs) in five genes with novel association to susceptibility. While there is little doubt that the novel susceptibility markers produced from such highly powered studies are true, the mechanisms by which they cause the susceptibility remain undetermined. We have looked at the expression levels of the identified genes in tumours and found that they are highly significantly differentially expressed between the five established breast cancer subtypes. Also, a significant association between SNPs in these genes and their expression in tumours was seen as well as a significantly different frequency of the SNPs between the subtypes. This suggests that the observed genes are associated with different breast cancer subtypes, and may exert their effect through their expression in the tumours. Thus, future studies stratifying patients by their molecular subtypes may give much more power to classic case control studies, and genes of no or borderline significance may appear to be high-penetrant for certain subtypes and, therefore, be identifiable.
MeSH Terms
Analysis of Variance
Apoptosis Regulatory Proteins
Biomarkers, Tumor/analysis,genetics
Breast Neoplasms/chemistry,genetics,pathology
Female
Gene Expression Regulation, Neoplastic
Genetic Predisposition to Disease
High Mobility Group Proteins
Humans
MAP Kinase Kinase Kinase 1/analysis,genetics
Microfilament Proteins/analysis,genetics
Polymorphism, Single Nucleotide
RNA, Long Noncoding
RNA, Untranslated/analysis,genetics
Receptor, Fibroblast Growth Factor, Type 2/analysis,genetics
Receptors, Progesterone/analysis,genetics
Trans-Activators
Up-Regulation
Chemicals
Apoptosis Regulatory Proteins
Biomarkers, Tumor
H19 long non-coding RNA
High Mobility Group Proteins
LSP1 protein, human
Microfilament Proteins
RNA, Long Noncoding
RNA, Untranslated
Receptors, Progesterone
TOX3 protein, human
Trans-Activators
FGFR2 protein, human
Receptor, Fibroblast Growth Factor, Type 2
MAP Kinase Kinase Kinase 1
MAP3K1 protein, human
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Nordgard Silje H
Department of Genetics, Institute of Cancer Research, Rikshospitalet-Radiumhospitalet Medical Centre, Montebello, N-0310 Oslo, Norway.
Johansen Fredrik E
Alnaes Grethe I G
Naume Bjørn
Børresen-Dale Anne-Lise
Kristensen Vessela N
References (7)
7 references, click to expand
-
Repeated observation of breast tumor subtypes in independent gene expression data sets.
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23
PMID: 12829800
-
Genome-wide association study identifies novel breast cancer susceptibility loci.
Nature. 2007 Jun 28;447(7148):1087-93
PMID: 17529967
-
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.
Nat Genet. 2007 Jul;39(7):870-4
PMID: 17529973
-
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.
Nat Genet. 2007 Jul;39(7):865-9
PMID: 17529974
-
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
PMID: 11553815
-
Molecular portraits of human breast tumours.
Nature. 2000 Aug 17;406(6797):747-52
PMID: 10963602
-
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer.
Mol Oncol. 2007 Sep;1(2):160-71
PMID: 19383292